Kevin S. Boyle Sr.

Insider Reports History

Location
Boston, MA
Signature
/s/ Melinda Lackey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin S. Boyle Sr.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alaunos Therapeutics, Inc. Chief Executive Officer, Director Common Stock 798,236 $111,993 $0.1403 01 Sep 2023 Direct

Insider Reports Filed by Kevin S. Boyle Sr.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCRT Alaunos Therapeutics, Inc. 01 Sep 2023 1 -$9,542 4 Chief Executive Officer, Director 05 Sep 2023, 17:34
TCRT Alaunos Therapeutics, Inc. 15 Mar 2023 1 $0 4 Chief Executive Officer, Director 17 Mar 2023, 20:30
TCRT Alaunos Therapeutics, Inc. 30 Aug 2022 1 -$45,188 4 Chief Executive Officer, Director 01 Sep 2022, 16:30
TCRT Alaunos Therapeutics, Inc. 30 Mar 2022 1 $0 4 Chief Executive Officer, Director 01 Apr 2022, 16:30
TCRT ZIOPHARM ONCOLOGY INC 16 Nov 2021 2 +$14,000 4 Chief Executive Officer, Director 17 Nov 2021, 15:53
TCRT ZIOPHARM ONCOLOGY INC 30 Aug 2021 2 $0 4 Chief Executive Officer, Director 31 Aug 2021, 16:42
TCRT ZIOPHARM ONCOLOGY INC 30 Aug 2021 0 $0 3 Chief Executive Officer, Director 31 Aug 2021, 16:37